ONCO · Onconetix, Inc.
$0.76
-0.05 (-6.63%)
At close · Aug 17
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because of historical and expected operating losses and net operating cash flow deficits, there is substantial doubt about the Company's ability to continue as a going concern for one year from the issuance of the unaudited condensed consolidated financial statements, which is not alleviated by management's plans.”View the 10-Q filed Aug 13, 2026
Market Cap
$2.99M
Shares
3.95M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Ralph Schiess | Former Interim Chief Executive Officer and Former Chief Science Officer | $305,176 |
| Christian Brühlmann | Former Chief Strategy Officer | $265,176 |
| Bruce Harmon | Former Chief Financial Officer | $232,644 |
| Karina Fedasz | Interim Chief Executive Officer and Interim Chief Financial Officer | $197,125 |
| Neil Campbell | Former Chief Executive Officer | $163,814 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Erin Henderson | Former Chief Business Officer and Corporate Secretary | $550,972 |
| Joseph Hernandez | Former Chief Executive Officer | $525,625 |
| Jon Garfield | Former Chief Financial Officer | $492,542 |
| Neil Campbell | Former Chief Executive Officer | $376,169 |
| Christian Brühlmann | Former Chief Strategy Officer | $186,795 |
| Bruce Harmon | Former Chief Financial Officer | $165,043 |
| Ralph Schiess | Former Interim Chief Executive Officer and Former Chief Science Officer | $105,545 |
| Karina Fedasz | Interim Chief Executive Officer and Interim Chief Financial Officer | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Joseph Hernandez | Former Chief Executive Officer | $1,703,376 |
| Erin Henderson | Former Chief Business Officer and Corporate Secretary | $1,233,354 |
| Jon Garfield | Former Chief Financial Officer | $903,059 |
| Bruce Harmon | Former Chief Financial Officer | — |
| Neil Campbell | Former Chief Executive Officer | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Joseph Hernandez | Chief Executive Officer | $630,000 |
| Erin Henderson | Chief Business Officer and Corporate Secretary | $171,173 |
| Jon Garfield | Chief Financial Officer | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Joseph Hernandez | Chief Executive Officer | $420,000 |
| Erin Henderson | Chief Business Officer and Corporate Secretary | $112,384 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Josh Epstein | member of the Board | Appointed | 2026-04-24 |
| Sammy Dorf | Chairman of the Board | Appointed | 2026-04-24 |
| Thomas Meier | Director | Resigned | 2026-04-24 |
| Andrew Oakley | Chairman of the Board | Resigned | 2026-04-24 |
| Andrew Oakley | Director | Resigned | 2026-04-24 |
| Sammy Dorf | member of the Board and a member of the Audit Committee of the Board | Appointed | 2026-03-24 |
| Timothy Ramdeen | member of the Board | Resigned | 2026-03-24 |
| David White | Chief Executive Officer | Appointed | 2026-03-24 |
| Ajit Singh | member of the Board of Directors | Resigned | 2025-08-12 |
| James Sapirstein | member of the Board of Directors | Resigned | 2025-04-03 |
| Karina Fedasz | Interim Chief Executive Officer | Appointed | 2025-04-03 |
| James Sapirstein | Executive Chairman | Resigned | 2025-04-03 |
| Thomas Meier | Chairman of the Compensation Committee | Appointed | 2025-02-28 |
| Andrew Oakley | Class II director | Appointed | 2025-02-28 |
| James Sapirstein | Executive Chairman | Appointed | 2025-02-28 |
| Dr. Ralph Schiess | Chief Science Officer | Resigned | 2025-02-28 |
| Dr. Ralph Schiess | Interim Chief Executive Officer | Resigned | 2025-02-28 |
| Christian Brühlmann | Chief Strategy Officer | Resigned | 2025-02-18 |
| Karina M. Fedasz | Interim Chief Financial Officer | Appointed | 2024-06-13 |
| Bruce Harmon | Chief Financial Officer | Resigned | 2024-06-13 |
| Ajit Singh | Class III director | Appointed | 2024-02-13 |
| Thomas Meier, PhD | Class I director | Appointed | 2024-02-12 |
| Erin Henderson | Chief Business Officer | Resigned | 2024-01-19 |
| James Sapirstein | Lead Independent Director | Appointed | 2024-01-12 |
| Dr. Ralph Schiess | Interim Chief Executive Officer | Appointed | 2024-01-12 |